Nine for 2021: The COVID-19 legacy
pharmaphorum
JANUARY 5, 2021
These are the crisis of healthcare system capacity and non COVID-19 patient backlog, and the economic crisis, still largely to come in impact, which will constrain healthcare spend, both public and private, across countries and have knock-on impacts for medicines spend.
Let's personalize your content